These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2767870)

  • 21. Mucosal epithelial proliferation of the fallopian tube: prevalence, clinical associations, and optimal strategy for histopathologic assessment.
    Yanai-Inbar I; Silverberg SG
    Int J Gynecol Pathol; 2000 Apr; 19(2):139-44. PubMed ID: 10782410
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nongynecologic metastases to fallopian tube mucosa: a potential mimic of tubal high-grade serous carcinoma and benign tubal mucinous metaplasia or nonmucinous hyperplasia.
    Rabban JT; Vohra P; Zaloudek CJ
    Am J Surg Pathol; 2015 Jan; 39(1):35-51. PubMed ID: 25025442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation.
    Russo A; Czarnecki AA; Dean M; Modi DA; Lantvit DD; Hardy L; Baligod S; Davis DA; Wei JJ; Burdette JE
    Oncogene; 2018 Apr; 37(15):1976-1990. PubMed ID: 29367766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Serous papillary cancer of the endometrium].
    Karseladze AI
    Arkh Patol; 1987; 49(8):30-5. PubMed ID: 3675216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium.
    Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B
    Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoimplants in serous borderline tumors of the ovary: a clinicopathologic study of 30 cases of a process to be distinguished from serous adenocarcinoma.
    Rollins SE; Young RH; Bell DA
    Am J Surg Pathol; 2006 Apr; 30(4):457-62. PubMed ID: 16625091
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube.
    Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW
    BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early adenocarcinoma of the fallopian tubes. A case for multifocal tumorigenesis.
    Bannatyne P; Russell P
    Diagn Gynecol Obstet; 1981; 3(1):49-60. PubMed ID: 7215124
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidental serous tubal intraepithelial carcinoma and early invasive serous carcinoma in the nonprophylactic setting: analysis of a case series.
    Morrison JC; Blanco LZ; Vang R; Ronnett BM
    Am J Surg Pathol; 2015 Apr; 39(4):442-53. PubMed ID: 25517955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Invasive ovarian endometrioid adenofibroma with omental implants and collision with endometrial adenocarcinoma.
    Gaing AA; Kimble CC; Belmonte AH; Agustin E; Tchertkoff V
    Obstet Gynecol; 1988 Mar; 71(3 Pt 2):440-4. PubMed ID: 3347431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Salpingitis, salpingoliths, and serous tumors of the ovaries: is there a connection?
    Seidman JD; Sherman ME; Bell KA; Katabuchi H; O'Leary TJ; Kurman RJ
    Int J Gynecol Pathol; 2002 Apr; 21(2):101-7. PubMed ID: 11917218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine serous papillary carcinoma: histopathologic changes within the female genital tract.
    Jordan LB; Abdul-Kader M; Al-Nafussi A
    Int J Gynecol Cancer; 2001; 11(4):283-9. PubMed ID: 11520366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ovarian cancer survival by tumor dominance, a surrogate for site of origin.
    Ivanova A; Loo A; Tworoger S; Crum CP; Fan I; McLaughlin JR; Rosen B; Risch H; Narod SA; Kotsopoulos J
    Cancer Causes Control; 2015 Apr; 26(4):601-8. PubMed ID: 25771796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hilus cell hyperplasia of fallopian tubes: a rare and incidental finding with uterine leiomyomas.
    Ansari IA; Prakash G; K R; V E; Bhat S
    Kathmandu Univ Med J (KUMJ); 2014; 12(45):64-6. PubMed ID: 25219998
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The presence of mucosal iron in the fallopian tube supports the "incessant menstruation hypothesis" for ovarian carcinoma.
    Seidman JD
    Int J Gynecol Pathol; 2013 Sep; 32(5):454-8. PubMed ID: 23896711
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EphA5 protein, a potential marker for distinguishing histological grade and prognosis in ovarian serous carcinoma.
    Chen X; Wang X; Wei X; Wang J
    J Ovarian Res; 2016 Nov; 9(1):83. PubMed ID: 27887627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expansion of secretory cells in the fallopian tubal epithelium in the early stages of the pathogenesis of ovarian serous carcinomas].
    Asaturova AV; Ezhova LS; Faizullina NM; Adamyan LV; Khabas GN; Sannikova MV
    Arkh Patol; 2017; 79(3):10-18. PubMed ID: 28631711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
    Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
    Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intraperitoneal serous adenocarcinoma: a critical appraisal of three hypotheses on its cause.
    Piek JM; Kenemans P; Verheijen RH
    Am J Obstet Gynecol; 2004 Sep; 191(3):718-32. PubMed ID: 15467531
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.